Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

COCP

Cocrystal Pharma Inc

Apr 28 • 04:00PM ET

1.39

-0.01 -0.71 %

Healthcare • Biotechnology • USA • Nano • NASD

Peers: MRNA BNTX GILD REGN PFE JNJ VRTX AZN-D NVAX SNY

| Held by: VTI VXF

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.79	Insider Own	34.28%	Shs Outstand	13.78M	Perf Week	-2.80%
Market Cap	19.16M	Forward P/E	-	EPS next Y	-0.64	Insider Trans	5.09%	Shs Float	9.06M	Perf Month	34.95%
Enterprise Value	13.56M	PEG	-	EPS next Q	-0.15	Inst Own	5.57%	Short Float	10.91%	Perf Quarter	36.27%
Income	-8.83M	P/S	-	EPS this Y	14.10%	Inst Trans	4.80%	Short Ratio	0.41	Perf Half Y	17.80%
Sales	0.00M	P/B	3.03	EPS next Y	4.48%	ROA	-76.23%	Short Interest	0.99M	Perf YTD	41.98%
Book/sh	0.46	P/C	2.70	EPS next 5Y	3.54%	ROE	-111.40%	52W High	2.67 -47.94%	Perf Year	-15.76%
Cash/sh	0.52	P/FCF	-	EPS past 3/5Y	45.26% -34.96%	ROIC	-117.72%	52W Low	0.86 61.85%	Perf 3Y	-43.95%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	5.11% 10.30%	Perf 5Y	-90.81%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	54.05%	Oper. Margin	-	ATR (14)	0.11	Perf 10Y	-99.43%
Dividend Ex-Date	-	Quick Ratio	3.68	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	53.62	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	3.68	EPS Q/Q	45.17%	SMA20	-1.45%	Beta	1.47	Target Price	9.00
Payout	-	Debt/Eq	0.24	Sales Q/Q	-	SMA50	17.21%	Rel Volume	0.03	Prev Close	1.40
Employees	10	LT Debt/Eq	0.18	Earnings	Mar 31 BMO	SMA200	13.88%	Avg Volume	2.42M	Price	1.39
IPO	Apr 01, 2008	Option/Short	No / Yes	EPS/Sales Surpr.	8.57% -	Trades		Volume	74,596	Change	-0.71%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)